Humana Inc. $HUM Stock Holdings Boosted by Czech National Bank

Czech National Bank lifted its position in Humana Inc. (NYSE:HUM) by 4.1% during the second quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 34,174 shares of the insurance provider’s stock after buying an additional 1,332 shares during the period. Czech National Bank’s holdings in Humana were worth $13,575,000 at the end of the most recent reporting period.

Other institutional investors have also modified their holdings of the company. PensionDanmark Pensionsforsikringsaktieselskab boosted its stake in Humana by 10.4% during the second quarter. PensionDanmark Pensionsforsikringsaktieselskab now owns 20,163 shares of the insurance provider’s stock valued at $8,009,000 after buying an additional 1,900 shares in the last quarter. 55 North Private Wealth LLC acquired a new position in Humana during the second quarter worth about $223,000. GAMMA Investing LLC raised its position in Humana by 79.9% in the second quarter. GAMMA Investing LLC now owns 1,567 shares of the insurance provider’s stock worth $622,000 after acquiring an additional 696 shares in the last quarter. Trinity Financial Advisors LLC acquired a new stake in Humana in the 2nd quarter valued at about $398,000. Finally, CoreCap Advisors LLC lifted its holdings in Humana by 74.7% in the 2nd quarter. CoreCap Advisors LLC now owns 159 shares of the insurance provider’s stock valued at $63,000 after acquiring an additional 68 shares during the last quarter. Institutional investors and hedge funds own 92.38% of the company’s stock.

Humana Trading Up 4.7%

Shares of HUM opened at $384.44 on Friday. The business’s 50-day moving average price is $377.18 and its 200 day moving average price is $271.65. The company has a current ratio of 1.74, a quick ratio of 1.74 and a debt-to-equity ratio of 0.62. The stock has a market capitalization of $46.16 billion, a P/E ratio of 36.37, a P/E/G ratio of 2.20 and a beta of 0.72. Humana Inc. has a 1-year low of $163.11 and a 1-year high of $428.88.

Humana (NYSE:HUM) last posted its quarterly earnings data on Wednesday, July 29th. The insurance provider reported $7.61 EPS for the quarter, beating analysts’ consensus estimates of $7.27 by $0.34. The company had revenue of $40.89 billion during the quarter, compared to analyst estimates of $40.58 billion. Humana had a net margin of 0.88% and a return on equity of 11.20%. The business’s quarterly revenue was up 26.2% on a year-over-year basis. During the same period in the prior year, the firm earned $6.27 earnings per share. Analysts expect that Humana Inc. will post 9.08 earnings per share for the current year.

Analyst Ratings Changes

Several equities analysts have recently issued reports on HUM shares. UBS Group began coverage on shares of Humana in a research note on Thursday, July 30th. They issued a “buy” rating on the stock. Royal Bank Of Canada increased their target price on shares of Humana from $246.00 to $415.00 and gave the company a “sector perform” rating in a research note on Thursday, July 9th. Wells Fargo & Company upgraded shares of Humana from an “equal weight” rating to an “overweight” rating and raised their target price for the stock from $227.00 to $502.00 in a report on Monday, July 13th. Morgan Stanley upgraded shares of Humana from an “underweight” rating to an “equal weight” rating and lifted their price target for the stock from $249.00 to $370.00 in a research report on Tuesday. Finally, Mizuho upped their price target on Humana from $335.00 to $390.00 and gave the company an “outperform” rating in a report on Monday, June 8th. One research analyst has rated the stock with a Strong Buy rating, fourteen have assigned a Buy rating, fourteen have issued a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, Humana presently has a consensus rating of “Moderate Buy” and a consensus price target of $391.87.

Humana Profile

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.